THE LIVINGSTON GROUP, LLC

Lobbying for INNOVATIVE VACCINE TECHNOLOGIES · Bio tech company

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 14, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Utah

Lobbying activity 2

Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.